Secondary treatment of advanced cancer of the prostate with Zoladex.
Int Urol Nephrol
; 22(4): 359-62, 1990.
Article
en En
| MEDLINE
| ID: mdl-2146234
Twelve patients with advanced prostatic carcinoma and relapse following previous hormone manipulation therapy were treated with Zoladex-depot every 4 weeks. The treatment was well tolerated and the endocrine response was satisfactory. However, no clinically important improvement was obtained.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias de la Próstata
/
Buserelina
Límite:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Int Urol Nephrol
Año:
1990
Tipo del documento:
Article
País de afiliación:
Dinamarca